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Neuronal cholesterol metabolism 
increases dendritic outgrowth and 
synaptic markers via a concerted 
action of GGTase-I and Trk
Miguel Moutinho1, Maria João Nunes1, Jorge C. Correia2, Maria João Gama1,3, 
Margarida Castro-Caldas1,4, Angel Cedazo-Minguez5, Cecília M. P. Rodrigues1,3, 
Ingemar Björkhem6, Jorge L Ruas2 & Elsa Rodrigues1,3
Cholesterol 24-hydroxylase (CYP46A1) is responsible for brain cholesterol elimination and therefore 
plays a crucial role in the control of brain cholesterol homeostasis. Altered CYP46A1 expression has 
been associated with several neurodegenerative diseases and changes in cognition. Since CYP46A1 
activates small guanosine triphosphate-binding proteins (sGTPases), we hypothesized that CYP46A1 
might be affecting neuronal development and function by activating tropomyosin-related kinase (Trk) 
receptors and promoting geranylgeranyl transferase-I (GGTase-I) prenylation activity. Our results 
show that CYP46A1 triggers an increase in neuronal dendritic outgrowth and dendritic protrusion 
density, and elicits an increase of synaptic proteins in the crude synaptosomal fraction. Strikingly, 
all of these effects are abolished by pharmacological inhibition of GGTase-I activity. Furthermore, 
CYP46A1 increases Trk phosphorylation, its interaction with GGTase-I, and the activity of GGTase-I, 
which is crucial for the enhanced dendritic outgrowth. Cholesterol supplementation studies indicate 
that cholesterol reduction by CYP46A1 is the necessary trigger for these effects. These results were 
confirmed in vivo, with a significant increase of p-Trk, pre- and postsynaptic proteins, Rac1, and 
decreased cholesterol levels, in crude synaptosomal fractions prepared from CYP46A1 transgenic 
mouse cortex. This work describes the molecular mechanisms by which neuronal cholesterol 
metabolism effectively modulates neuronal outgrowth and synaptic markers.
Dysfunction in brain cholesterol homeostasis has been widely associated with neurodegenerative disorders 
and cognitive decline1. The neuronal-specific cytochrome P450 cholesterol 24-hydroxylase (CYP46A1) is a 
major player in brain cholesterol homeostasis. This enzyme is responsible for the conversion of cholesterol into 
24S-hydroxycholesterol (24OHC), the major pathway for brain cholesterol elimination2–5. CYP46A1 polymor-
phisms have been associated with higher risk of Alzheimer´s disease (AD)6,7 and faster course of cognitive dete-
rioration in late life8,9. Interestingly, in mouse models of AD, delivery of CYP46A1 to the brain by a recombinant 
virus vector reduces amyloid pathology before or after the onset of amyloid plaques10. Conversely, delivery of 
short hairpin RNA directed against the mouse Cyp46a1 mRNA leads to an increase of cholesterol levels in neu-
rons, followed by amyloidogenesis and neuronal loss11. Additionally, cholesterol 24-hydroxylase modulates brain 
cholesterol synthesis by a feedback mechanism that regulates the mevalonate pathway. In fact, the mevalonate 
pathway is suppressed in the brain of Cyp46a1 knockout (Cyp46a1−/−) mice12, and activated in homozygous 
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CYP46A1 transgenic (C46-HA) mouse brain, maintaining cholesterol at physiological levels13. Interestingly, 
Cyp46a1−/− mice exhibit severe deficiencies in spatial, associative, and motor learning, and in hippocampal 
long-term potentiation. In contrast, C46-HA mice exhibit an improved cognitive performance, when compared 
to wild type (WT) mice12,13. However, although the mechanisms by which CYP46A1, the major enzyme of brain 
cholesterol metabolism, affects neuronal function are not clear, the differences in cognitive function are likely 
due to changes in the supply of isoprenoid intermediates of the mevalonate pathway5,12,14, which are essential for 
protein prenylation. Indeed, we have recently demonstrated that increased CYP46A1 expression induces preny-
lation, namely geranylgeranylation and activity of small guanosine triphosphate-binding proteins (sGTPases) 
in neuronal cells15. The activity of sGTPases has been extensively related to neuronal development and func-
tion. It has been recently described that geranylgeranyl transferase I (GGTase-I), the enzyme responsible for 
geranylgeranylation of sGTPases, is activated by brain-derived neurothrophic factor (BDNF), through direct 
protein-protein interaction with the tropomyosin-related kinase B (TrkB) receptors, which seems to be crucial 
for BDNF-induced dendritic development16. On the other hand, it has been reported that cholesterol loss leads 
to TrkB auto-activation17.
Taking these data into consideration, we hypothesized that there is a crosstalk between CYP46A1-induced 
sGTPase prenylation and Trk activation, which could mediate the beneficial effects of cholesterol 24-hydroxylase 
activity on neuronal development and function.
Herein we report that neuronal cholesterol metabolism, mediated by CYP46A1, promotes neuronal outgrowth 
and increases synaptic markers in a GGTase-I-dependent fashion. We show that the increased GGTase-I activity 
that results from the activation of the Trk-GGTase-I axis by CYP46A1 is crucial for the increment of dendritic 
outgrowth. This axis, however, does not appear to be essential for the increase in dendritic protrusion density 
mediated by CYP46A1. Nevertheless, although acting as independent mechanisms, both activation of Trk due to 
cholesterol loss, and GGTase-I activity are essential for the full effect of CYP46A1 on these synaptic structures.
This study describes the molecular mechanisms by which CYP46A1 modulates neuronal outgrowth and func-
tion, highlighting the cholesterol 24-hydroxylase as an attractive drug target in the physiological and pathological 
context of cognitive decline and brain disorders.
Results
CYP46A1 induces dendritic outgrowth in a GGTase-I dependent manner. We have recently shown 
that increased expression and activity of CYP46A1 induces the activation of the mevalonate pathway, which 
consequently leads to increased prenylation and activation of sGTPases, including Rho family proteins15. Since 
in neurons, Rho GTPases regulate several features of dendritic and axonal outgrowth during development and 
regeneration, mainly through their effects on the cytoskeleton, we started by evaluating the role of CYP46A1 on 
dendritic outgrowth in primary cultures of rat cortical neurons. Neurons kept for 4 days in vitro (DIV) were trans-
fected with a control plasmid harboring a CMV promoter, pCMV (Control), or the same plasmid encoding for 
the FLAG-tagged human CYP46A1, pCMV-FLAG-hCYP46A1 (hCYP) (Fig. 1A) and maintained for 48 hours. 
CYP46A1 protein and mRNA endogenous levels as well as the ectopic expression of FLAG-tagged CYP46A1 
and the levels of its product, 24OHC, in culture media are shown in Supplementary Fig. 1. As previously shown, 
CYP46A1 mRNA and protein levels increase during neuronal maturation in vitro (Supplementary Fig. 1A,B). 
Moreover, transfection of hCYP vector robustly increased CYP46A1 protein and 24OHC levels in neurons 
(Supplementary Fig. 1C,D). These cells were incubated with 100 nM GGTi-2133, a geranylgeranyl transferase-I 
(GGTase-I) inhibitor, or vehicle (DMSO) in the last 24 hours after transfection. Subsequently, neurons were fixed, 
stained with DAPI (nuclear stain) and immunostained with anti-FLAG and -MAP2 antibodies for dendritic out-
growth analysis at 6 DIV (Fig. 1B,C). Our results show that the number of both primary and secondary dendrites 
was significantly increased in hCYP-transfected neurons. However, inhibiting prenylation not only decreased the 
number of dendrites but it also impaired the CYP46A1-dependent effect (Fig. 1B) (Two-way ANOVA p < 0.001, 
Tukey HSD post hoc test). Results from Sholl analysis confirmed a significant increase in dendritic arbor complex-
ity after hCYP transfection, while the GGTi-2133 treatment decreased dendritic arborization and abolished the 
CYP46A1 effect (Fig. 1C). Particularly, CYP46A1 significantly increased the number of intersections at 16–25 μm 
from the soma when compared to control neurons. On the other hand, GGTi-2133 treatment decreased the 
basal number of intersections and inhibited the increase promoted by CYP46A1, respectively (two-way ANOVA 
p < 0.05, Tukey HSD post hoc test).
Since we have previously shown that 24OHC has a different effect on the activation of sGTPases than 
CYP46A1 ectopic expression15, and to determine if the CYP46A1-mediated effect on neuronal dendritic out-
growth is not dependent on the increased production of this oxysterol, we have treated 5 DIV neurons for 24 h 
with vehicle or 10 μM 24OHC. Quantitation of primary dentrites and dendritic arbor complexity was performed 
as previously described. Our results show that 24OHC has the opposite effect of CYP46A1 (Supplementary 
Fig. 2), since it significantly decreases dendritic outgrowth in vitro.
Overall, our results show that CYP46A1 ectopic expression promotes neuronal dendritic outgrowth in a 
GGTase-I dependent manner.
GGTase-I is necessary for the CYP46A1-mediated increase of dendritic protrusions and synaptic 
protein enrichment. Since we found that ectopic CYP46A1 expression in neurons leads to an increase in 
dendritic arbor complexity, we investigated if this would also affect dendritic protrusion density. Thus, mature 
neurons (19 DIV) were transfected with Control or hCYP plasmids, maintained for 48 hours, and in the last 
24 hours after transfection, cells were incubated with 100 nM GGTi-2133 or DMSO. Quantification of the number 
of dendritic protrusions was done at 21 DIV after neurons were fixed and stained with DAPI, phalloidin (F-actin 
stain) and immunostained with anti-FLAG antibodies (Fig. 2A). Our results show that the number of dentritic 
protusions increased by ~30% in hCYP-transfected neurons and that inhibition of prenylation not only decreased 
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dentritic protrusion density but also impaired the CYP46A1-dependent effect (two-way ANOVA p < 0.05, Tukey 
HSD post hoc test).
Dendritic protrusions constitute the primary loci of excitatory synaptic transmission in the mammalian cen-
tral nervous system. We therefore analysed if the increase in dentritic protusion density induced by CYP46A1 
overexpression was accompanied by an enrichment of synaptic proteins in the crude synaptosomal fraction (P2) 
isolated from these cells. The relative abundance of postsynaptic proteins PSD95 and Shank3, and of the presyn-
aptic protein synaptotagmin was analyzed by Western blot using specific antibodies (Fig. 2B). We observed a 
small but consistent and significant enrichment of PSD-95 and Shank3 in the isolated neuronal P2 fraction. The 
levels of synaptotagmin did not change between Control and hCYP-transfected neurons. Once again, treatment 
with GGTi-2133 impaired the CYP46A1-dependent increase in PSD-95 and Shank3 levels (two-way ANOVA 
p < 0.01, Tukey HSD post hoc test). To further confirm our observations, we isolated the crude synaptosomal 
fraction from the brain cortex of WT and transgenic C46-HA mice, and determined by immunoblotting the con-
tent of post- and presynaptic proteins (Fig. 2C). In agreement with the in vitro data, we observed an increase in 
Figure 1. CYP46A1 increases the number of primary and secondary dendrites and overall dendritic arbor 
complexity in a GGTase-I dependent manner. Primary cultures of rat cortical neurons kept for 4 days in vitro 
(4 DIV) were transfected with Control or hCYP vector and maintained for 48 hours. 24 hours after transfection, 
cells were incubated with 100 nM of GGTi-2133 or vehicle (DMSO). Neurons were stained with DAPI, and 
immunostained with anti-FLAG and -MAP2 antibodies for dendritic outgrowth analysis at 6 DIV.  
(A) Schematic structure of pCMV-FLAG-hCYP46A1 plasmid encoding for the enzyme CYP46A1 tagged 
with the FLAG epitope (B) Quantitation of primary and secondary dendrites of neurons in all experimental 
conditions. Images are representative of merged DAPI (blue), FLAG (red) and MAP2 (green) staining in 
Control and hCYP transfected neurons treated with DMSO or GGTi-2133. Scale bar: 20 μm. Data represents 
mean values ± SEM from at least three independent experiments and is expressed as number of dendrites. 
Statistical analysis was performed by two-way ANOVA followed by Tukey post-hoc test (*p < 0.05 **p < 0.01 
***p < 0.001). (C) Quantitation of dendritic arbor complexity. Sholl analysis was performed in neurons 
transfected with Control or hCYP vector and treated with DMSO or GGTi-2133. Images are representative 
of 6 DIV neurons in each condition. Scale bar: 20 μm. Data represents mean values ± SEM from at least three 
independent experiments and is plotted as number of intersections versus distance (μm) to soma. Statistical 
analysis was performed by two-way ANOVA and post-hoc Tukey test (*p < 0.05 **p < 0.01).
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Figure 2. CYP46A1 increases the number of dendritic protrusions and induces synaptic proteins 
enrichment in a GGTase-I dependent manner. (A,B) Primary cultures of rat cortical neurons 19 days in vitro 
(19 DIV) were transfected with Control or hCYP vector and maintained for 48 hours. 24 hours after transfection 
cells were incubated with 100 nM GGTi-2133 or vehicle (DMSO). Statistical analysis was performed by two-way 
ANOVA followed by Tukey post-hoc test (*p < 0.05 **p < 0.01 ***p < 0.001). (A) Quantitation of dendritic 
protrusion density. Dendritic protrusions were quantified in 21 DIV neurons stained with DAPI and phalloidin 
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PSD-95 and Shank3 expression in C46-HA mouse brain relative to WT controls. Additionally, we also observed 
an increase in the presynaptic protein synaptophysin (Fig. 2C).
These results indicate that CYP46A1 promotes an increase in dendritic protrusion density, accompanied by an 
enrichment of synaptic proteins at the synaptosomal level, in a GGTase-I dependent fashion.
CYP46A1 promotes phosphorylation of Trk and consequently increases GGTase-I activity. 
Cholesterol reduction was shown to increase phosphorylation and activation of Trk receptor in hippocampal 
neurons in vitro17. Additionally, BDNF-dependent activation of the TrkB receptor has been demonstrated to 
promote the physical interaction between TrkB and GGTase-I, and consequently, to increase GGTase-I prenyl-
ation activity16. Therefore, we hypothesized that in addition to enhancing sGTPase activity due to the increased 
isoprenoid pool15, CYP46A1 could also induce GGTase-I activity, as a result of Trk activation and consequent 
interaction with GGTase-I. Therefore, we started by assessing the phosphorylated Trk (p-Trk) levels in WT and 
C46-HA mouse brain, by Western blot analysis. We observed a significant increase in Trk phosphorylation levels 
in total protein extracts prepared from C46-HA mouse brain cortex (Fig. 3A). To test if the CYP46A1-dependent 
increase in p-Trk levels could affect protein-protein interaction between Trk and GGTase-I in vivo, we performed 
co-immunoprecipitation (Co-IP) assays (Fig. 3B). Our results show increased association between p-Trk and 
GGTase-I in C46-HA mouse brain. Indeed, immunoprecipitation (IP) of p-Trk caused the Co-IP of GGTase-I 
in total protein extracts of C46-HA mouse brain, while in the same experimental conditions, Co-IP of GGTase-I 
could not be detected in WT brain extracts (Fig. 3B). Additionally, IP of GGTase-I led to a Co-IP of p-Trk in both 
WT and C46-HA brain extracts, although in C46-HA the amount of p-Trk that co-immunoprecipitated with 
GGTase-I was higher compared to WT. The levels of p-Trk were increased in the total brain extracts of C46-HA 
mice (Fig. 3B), as previously observed (Fig. 3A), which led to the detection of higher levels of p-Trk after the IP 
of p-Trk itself or GGTase-I (Fig. 3B), reflecting an increased association of p-Trk with GGTase-I in the brains of 
C46-HA mice. Furthermore, to determine if the p-Trk-GGTase-I interaction induced by CYP46A1 positively 
affects GGTase-I activity, hCYP-transfected 6 DIV neurons were incubated with 100 nM K252a, a widely used 
inhibitor of Trk phosphorylation, for 24 hours, and the phosphorylation levels of Trk and GGTase-I activity were 
determined (Fig. 3C,D). Transfection of hCYP led to a modest but significant increase in Trk phosphorylation, 
in accordance with the in vivo data. However, when neurons were incubated with K252a, this effect could no 
longer be observed (Fig. 3C; two-way ANOVA p < 0.05, Tukey HSD post hoc test). Concomitantly, GGTase-I 
activity was increased ~2-fold in hCYP-transfected neurons, however, upon treatment with K252a, this effect was 
abolished. GGTi-2133 was used as a negative control for GGTase-I activity (Fig. 3D; one-way ANOVA p < 0.001, 
Tukey HSD post hoc test). Thus, CYP46A1 leads to an increase in GGTase-I activity, which is dependent on Trk 
phosphorylation and interaction between both proteins.
Trk activation is required for CYP46A1-dependent increase on dendritic outgrowth and 
partially necessary for its effect on dendritic protrusions. To determine how crucial Trk activation 
is for CYP46A1-dependent increase on dendritic outgrowth and protrusion density in neurons, we transfected 
4 DIV neurons with Control or hCYP vectors. Cells were maintained for 48 hours, and incubated with 100 nM 
K252a or vehicle in the last 24 hours after transfection (Fig. 4A,B). As expected, the number of primary and 
secondary dendrites was higher in neurons transfected with hCYP, and this effect was abolished when Trk phos-
phorylation was inhibited by K252a treatment (Fig. 4A; two-way ANOVA p < 0.001, Tukey HSD post hoc test). 
Moreover, Sholl analysis revealed that the increase in arbor complexity induced by CYP46A1 was inhibited in the 
presence of K252a (Fig. 4B; two-way ANOVA p < 0.05, Tukey HSD post hoc test). These results, together with data 
in Fig. 1, indicate that both Trk and GGTase-I activity are essential for the CYP46A1 effect on dendritic outgrowth. 
This is consistent with the fact that CYP46A1 led to an increased interaction between the two proteins, and to the 
activation of GGTase-I. Furthermore, we also investigated if Trk inhibition could impair CYP46A1-dependent 
increase on dendritic protrusion density (Fig. 4C,D). To facilitate the analysis and increase the number of 19 
DIV neurons expressing CYP46A1, we generated a recombinant adenovirus to express FLAG-tagged CYP46A1. 
Mature neurons were transduced with an adenovirus encoding GFP (AdControl), or encoding GFP and 
FLAG-tagged CYP46A1 (AdCYP) (expressed from two independent promoters) and maintained for 48 hours. 
The levels of CYP46A1 expression were increased ~3 fold, paralled by a significant increase in the levels of 
24OHC in culture media (Supplementary Fig. 3). In the last 24 hours, neurons were incubated with 100 nM 
GGTi-2133 or K252a and then fixed and immunostained for p-Trk. In agreement with our previous data from 
(F-actin stain), and immunostained with anti-FLAG antibody. Images are representative of phalloidin staining 
(green) in Control and hCYP transfected neurons treated with DMSO or GGTi-2133. Scale bar: 20 μm (upper 
panel) and 5 μm (lower panel). Data represents mean values ± SEM from at least three independent experiments 
and is expressed as number of dendritic protrusions per μm of the respective dendrite. (B) Determination of 
synaptic protein levels in crude synaptosomal fractions (P2). P2 fractions isolated from 21 DIV neurons were 
subjected to Western Blot analysis for the postsynaptic proteins PSD-95 and Shank3, and the presynaptic 
protein Synaptotagmin. β-actin was used as loading control. Data represents mean values ± SEM from at least 
three independent experiments and is expressed as fold to the control. (C) Synaptic proteins content in P2 
fractions of WT and C46-HA mice. P2 fractions of cortical tissue isolated from WT and C46-HA mouse brain 
were subjected to Western Blot analysis for the postsynaptic proteins PSD-95 and Shank3, and the presynaptic 
proteins Synaptophysin and Synaptotagmin. β-actin was used as loading control. Data represents mean 
values ± SEM from at least three independent experiments and is expressed as arbitrary units. Statistical analysis 
was performed by Student’s t-test (*p < 0.05 **p < 0.01).
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Figure 3. CYP46A1 induces phosphorylation of Trk in vivo and in vitro consequently increasing GGTase-I 
activity. (A) Total protein extract obtained from WT and C46-HA mice brain were subjected to Western Blot 
analysis for p-Trk and TrkB. β-actin was used as loading control. Data represents mean values ± SEM from 
at least three independent experiments and is expressed as fold of p-Trk/TrkB ratio relative to the control. 
Statistical analysis was performed by Student’s t-test (*p < 0.05). (B) Analysis of the interaction between 
p-Trk and GGTase-I proteins in the brains of WT and C46-HA mice. Immunoprecipitation (IP) experiments 
were carried out using total extracts from WT and C46-HA mouse brain and the anti-p-Trk and -GGTase-I 
antibodies (upper and lower panel, respectively). Resulting immunocomplexes were probed with p-TrkB or 
GGTase-I antibodies, and representative images of at least three independent experiments are shown. Input 
corresponds to 5% of tissue lysate and IgG H refers to the heavy chain of the antibodies used for IP. In the 
lower panel, the black lines (−) correspond to cropping lanes between samples that run in the same gel, under 
the same experimental conditions. (C,D) Primary cultures of rat cortical neurons 4 DIV were transfected 
with Control or hCYP vector and maintained for 48 hours. 24 hours after transfection, cells were incubated 
with 100 nM K252a, GGTi-2133, or vehicle (DMSO). Statistical analysis was performed by one- and two-way 
ANOVA followed by Tukey post-hoc test (*p < 0.05 **p < 0.01 ***p < 0.001). (C) Determination of p-Trk and 
TrkB levels in neuronal total protein extracts, by Western blot analysis. β-actin was used as loading control. Data 
represents mean values ± SEM from at least three independent experiments and is expressed as the p-Trk/TrkB 
ratio in arbitrary units. (D) Assessment of GGTase-I activity in neurons. Equal amounts of total extracts from 6 
DIV neurons were subjected to a GGTase-I fluorometric assay. Data represents mean values ± SEM from at least 
three independent experiments and is expressed as fold to the control.
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Figure 4. Trk activation is required for CYP46A1-dependent increase on dendritic outgrowth and 
partially necessary for its effect on dendritic protrusions. (A,B) Primary cultures of rat cortical neurons 4 
DIV were transfected with Control or hCYP vector and maintained for 48 hours. 24 hours after transfection, 
cells were incubated with 100 nM of K252a or vehicle (DMSO). Neurons were stained with DAPI (blue) and 
immunostained with anti-FLAG (red) and -MAP2 (green) antibodies for dendritic outgrowth analysis at 6 
DIV. Statistical analysis was performed by two-way ANOVA and post-hoc Tukey test (*p < 0.05 **p < 0.01 
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transient transfected 4 DIV neurons, p-Trk was increased in 19 DIV neurons transduced with AdCYP (Fig. 4C). 
Interestingly, in the presence of GGTi-2133, this effect was maintained, although, the overall p-Trk levels were 
decreased. As expected, when cells were incubated with K252a, p-Trk levels were strikingly decreased and the 
CYP46A1-dependent increase on Trk phosphorylation was abolished (one-way ANOVA p < 0.001, Tukey HSD 
post hoc test). These results are consistent with the fact that GGTase-I activation is a downstream consequence 
of Trk phosphorylation induced by CYP46A1, and inhibition of GGTase-I per se does not influence CYP46A1 
effect on p-Trk. Additionally, we also confirmed that the synaptic proteins PSD-95 and Shank3 are also increased 
in the P2 fraction of these AdCYP neurons (Supplementary Fig. 4), as previously assessed for hCYP-transfected 
21 DIV neurons. For the dendritic protrusion density analysis, we took advantage of transduced neurons express-
ing GFP, which allowed us to determine the number of protrusions and assess their co-localization with p-Trk in 
the different conditions tested (Fig. 4D). As previously shown, GGTi-2133 decreased the density of protrusions 
and abolished the increment induced by CYP46A1, while K252a has no effect (one-way ANOVA p < 0.001, Tukey 
HSD post hoc test). Furthermore, CYP46A1 strikingly increased p-Trk at dendritic protrusions, as observed by 
the percentage of co-localization of these structures with p-Trk. Interestingly, although GGTi-2133 decreased the 
number of protrusions, it did not alter the percentage of co-localization between protrusions and p-Trk. On the 
other hand, K252a reduced the percentage of protrusions that co-localize with p-Trk, but not the number of these 
structures (two-way ANOVA p < 0.001, Tukey HSD post hoc test). Thus, the increase in the number of dendritic 
protrusions elicited by CYP46A1 does not seem to dependent on Trk activation, and consequently, on the activa-
tion of the Trk-GGTase-I axis. Since we have already described that CYP46A1 activates the mevalonate pathway 
as a consequence of membrane cholesterol reduction, inducing prenylation and activation of sGTPases15, it is 
plausible that this mechanism might be sufficient on itself to drive a sGTPases-mediated remodeling of spines, 
occurring independently of Trk-induced GGTase-I activation.
In summary, CYP46A1 increases the number of dendritic protrusions and the presence of p-Trk in these 
structures. Inhibition of either Trk or GGTase-I does not completely abolish CYP46A1 effect, but partially affects 
it in a specific manner.
CYP46A1-induced dendritic outgrowth is triggered by the reduction in cellular cholesterol levels. 
To confirm if the trigger for the overall effect of CYP46A1 is dependent on the reduction of cholesterol levels, 
4 DIV neurons transfected with hCYP and maintained for 48 hours, were cultured for the last 24 h in media 
supplemented with 10 μM cholesterol (Chol:MBCD). Neurons were fixed and stained with filipin III (used to 
localize free cholesterol) and immunostained with anti-MAP2 antibody to analyze dendritic outgrowth (Fig. 5). 
We have previously reported that ectopic expression of CYP46A1 reduces cholesterol in the membrane fraction 
of neuronal cells15. Herein, although we could not detect differences in the level of free cholesterol in total extracts 
from cultures containing hCYP-transfected neurons (Supplementary Fig. 5), by analyzing filipin III staining in 
neurons that were specifically positive for FLAG staining, ie, transfected with hCYP, we could observed a 20% 
reduction in cholesterol levels (Fig. 5A). This decrease is paralleled by an increment in the number of primary 
dendrites (Fig. 5A) and a higher dendritic arbor complexity, determined by Sholl analysis (Fig. 5B). The induction 
of dendritic outgrowth by CYP46A1 is abolished upon cholesterol supplementation to neurons. Moreover, higher 
levels of neuronal cholesterol, due to media supplementation, have a negative effect on dendritic outgrowth. 
(Fig. 5A,B) (two-way ANOVA p < 0.05, Tukey HSD post hoc test). Although cholesterol accumulation might 
render a toxic effect or an increased susceptibility to toxic stimuli11,18–20, besides the morphological differences, 
we did not detect significant changes in cell death markers, namely lactate dehydrogenase (LDH) or adenylate 
kinase (AK) activity in culture media, between cholesterol supplementation conditions and respective controls 
(Supplementary Fig. 6). These data indicate that cholesterol reduction is the necessary trigger for the increase of 
dendritic outgrowth mediated by CYP46A1.
The effect of CYP46A1 on dendritic protrusions and p-Trk levels is dependent on cholesterol 
reduction. Since we found that a reduction in cholesterol levels is essential for the CYP46A1-mediated 
***p < 0.001). Scale bar: 20 μm. (A) Quantitation of primary and secondary dendrites of analysed neurons. 
Representative merged images are shown. Data represents mean values ± SEM from at least three independent 
experiments and is expressed as number of dendrites. (B) Quantitation of dendritic arbor complexity by Sholl 
analysis. Images are representative of 6 DIV neurons and data represents mean values ± SEM from at least  
three independent experiments and is plotted as number of intersections versus distance (μm) to soma.  
(C,D) Primary cultures of rat cortical neurons 19 DIV were transduced with AdControl or AdCYP adenovirus 
and maintained for 48 hours. 24 hours after transduction cells were incubated with 100 nM GGTi-2133, K252a 
or vehicle (DMSO). Neurons were immunostained with anti-p-Trk (red). Statistical analysis was performed by 
one-way ANOVA followed by Tukey post-hoc test. (C) Quantitation of p-Trk levels. Images are representative 
of 21 DIV neurons exhibiting GFP (green). p-Trk levels were determined by measuring the fluorescence and 
normalizing by the area of the respective neuron. Scale bar: 20 μm. Data represents mean values ± SEM from 
at least three independent experiments and is expressed as fold change over control (*p < 0.05 **p < 0.01 vs 
Control-DMSO; §p < 0.001 vs hCYP-DMSO; ‡p < 0.01 vs Control-GGTi-2133). (D) Quantitation of dendritic 
protrusion density of 21 DIV neurons exhibiting GFP. The percentage of co-localization between protrusions 
and p-Trk immunostaining was determined. Scale bar: 5 μm. Representative images are shown and data 
represents mean values ± SEM from at least three independent experiments and is expressed as number of 
protrusions per μm of the respective dendrite (left chart) and percentage of co-localization between p-Trk and 
protrusions (right chart) (*p < 0.05 **p < 0.01 ***p < 0.001).
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increase of dendritic outgrowth, we wanted to confirm if the trigger for the overall effect of CYP46A1 on den-
dritic protrusions and p-Trk was also dependent on the reduction of cholesterol levels. 19 DIV neurons trans-
duced with AdCYP and maintained for 48 hours, were supplemented with 10 μM cholesterol (Chol:MBCD) in the 
culture media during the last 24 hours. Neurons were fixed and stained with filipin III and immunostained with 
an anti-p-Trk antibody (Fig. 6A,B). Similarly to what was observed in 4 DIV neuronal cultures, cholesterol levels 
in total extracts obtained from cultures transduced with AdCYP do not change when compared to the control 
(Supplementary Fig. 7). However, when analyzing neurons specifically transduced with AdCYP using filipin III, 
we observed a decrease in free cholesterol levels (Fig. 6A). Consistent with previous data17, this decrease in choles-
terol is concomitant with increased p-Trk levels. When the culture media was supplemented with cholesterol, we 
Figure 5. Cholesterol reduction is necessary for CYP46A1 induced dendritic outgrowth. (A,B) Primary 
cultures of rat cortical 4DIV neurons were transfected with Control or hCYP vector and maintained for 
48 hours. 24 hours after transfection cells were incubated with 10 μM cholesterol (Chol:MBCD). Neurons were 
stained with filipin III (free cholesterol staining) and immunostained for MAP2 and FLAG. Scale bar: 20 μm. 
Statistical analysis was performed by two-way ANOVA followed by Tukey post-hoc test (*p < 0.05 **p < 0.01 
***p < 0.001) (A) Quantitation of filipin III levels and primary dendrites. Representative merged images of 
filipin III (blue), FLAG (green) and MAP2 (red) staining, in Control and hCYP transfected 6DIV neurons 
supplemented with vehicle or 10 μM Chol:MBCD. Average filipin III fluorescence intensity was measured 
in neurons and normalized to the respective area. Data represents mean values ± SEM from at least three 
independent experiments and is expressed as fold change over control. (B) Quantitation of dendritic arbor 
complexity. Sholl analysis was performed in neurons transfected with Control or hCYP vector and treated with 
vehicle or Chol:MBCD. Images are representative of 6 DIV neurons in each condition. Data represents mean 
values ± SEM from at least three independent experiments and is plotted as number of intersections versus 
distance (μm) to soma.
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Figure 6. Cholesterol reduction is a necessary trigger for the CYP46A1-dependent increase in dendritic 
protrusion density and p-Trk levels. (A,B) Primary cultures of rat cortical neurons 19 DIV were transduced 
with AdControl or AdCYP adenovirus and maintained for 48 hours. 24 hours after transduction cells were 
incubated with 10 μM Chol:MBCD. Neurons were stained with filipin III (blue) and immunstained with p-Trk 
(red). Statistical analysis was performed by two-way ANOVA followed by Tukey post-hoc test (*p < 0.05 
**p < 0.01 ***p < 0.001). (A) Quantitation of filipin III and p-Trk levels. Images are representative of 21 
DIV neurons exhibiting GFP (green), stained with filipin III and immunostained with p-Trk. Filipin III and 
p-Trk levels were determined by measuring the average fluorescence intensity in neurons and normalized 
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could no longer observe the decrease in filipin staining and increased Trk phosphorylation induced by CYP46A1 
(two-way ANOVA p < 0.05, Tukey HSD post hoc test). Furthermore, cholesterol supplementation also abolished 
the increase in dendritic protrusion density and p-Trk levels in these structures triggered by CYP46A1 (Fig. 6B, 
two-way ANOVA p < 0.01, Tukey HSD post hoc test). This was also confirmed in vivo (Fig. 6C,D). Firstly, we 
found a reduction of cholesterol levels in the crude synaptossomal P2 fraction isolated from C46-HA mouse 
brain cortex when comparing to the WT (Fig. 6C). Strikingly, we detected a 3-fold increase in the levels of phos-
phorylated Trk in the P2 fraction (Fig. 6D). Interestingly, levels of Rac1, a Rho GTPase well known for its role in 
neuronal function and morphological events, including dendritic outgrowth and spine formation21–24, were also 
significantly increased in the P2 fraction of C46-HA mouse brain cortex (Fig. 6E). This is in line with the fact that 
CYP46A1 induces significant morphological changes, namely the increase in dendritic protrusion density.
These data indicate that the reduction in cellular cholesterol mediated by CYP46A1 is the crucial trigger for 
the subsequent increase in p-Trk levels and protrusion density.
The effect of neuronal cholesterol metabolism mediated by CYP46A1 on the expression 
levels of synaptic genes. Since we found that CYP46A1 increases synaptic proteins and dendritic pro-
trusion density, we decided to determine the mRNA profile of genes associated with synaptic function in 19 
DIV neurons transduced with AdCYP and maintained for 48 hours. We confirmed the ectopic expression of the 
human CYP46A1 (Fig. 7A), and observed comcomitant significant changes in the mRNA levels of Arc, Gria2 and 
Grin2b of ~1.3, 1.4 and 1.5 fold, respectively (Fig. 7B). Since the previously described neuronal effects induced by 
CYP46A1 rely primarly on cholesterol reduction, and subsequently on Trk activation and/or GGTase-I activity, 
we analyzed if the alterations on gene expression levels induced by CYP46A1 were altered in the presence GGTi-
2133, K252a, or cholesterol supplementation. Importantly, we observed that none of these compounds affect 
the basal mRNA levels of Arc, Gria2 or Grin2b (Supplementary Fig. 8). Interestingly, neurons transduced with 
AdCYP and incubated with 100 nM GGTi-2133 did not exhibit increments in Gria2 and Grin2b mRNA levels, 
although expression levels of Arc were increased by ~1.4 fold (Fig. 7C). On the other hand, in the presence of 
100 nM K252a, neurons transduced with AdCYP revealed an increase in Gria2 mRNA levels by ~1.3 fold, while 
Arc and Grin2b levels did not change (Fig. 7C). Importantly, AdCYP transduced neurons incubated with media 
supplemented with 10 μM cholesterol (Chol:MBCD), did not exhibit any increase in the mRNA levels of Arc, 
Gria2 and Grin2b (Fig. 7C). Taken together, these results indicate that cholesterol reduction is necessary for the 
overall changes in gene expression elicited by CYP46A1, although the specific underlying mechanism seem to 
differ between different genes.
All these data from 6 and 22 DIV neurons transfected and transduced, respectively, with CYP46A1, and incu-
bated with cholesterol-supplemented media, suggest that cholesterol reduction is the primary and crucial trigger 
for the neuronal effects arising from CYP46A1 expression concerning dendritic outgrowth and synaptic function.
Discussion
CYP46A1 is the major regulator of brain cholesterol elimination. Although the underlying mechanisms are not 
clear, increased levels of this enzyme have been extensively associated with improved cognitive function in phys-
iological and pathological conditions10,13,20. For this reason, CYP46A1 has been envisioned as an appealing drug 
target for the treatment of neurodegenerative disorders.
This study uncovers the molecular basis underlying the impact of CYP46A1 on high-order brain functions. 
Indeed, herein we describe that an increase in CYP46A1 expression induces neuronal dendritic outgrowth, den-
dritic protrusion density, synaptic genes, and elicits an increase of synaptic proteins in the synaptosomal fraction 
in vivo and in vitro. All of these morphological and molecular changes promoted by increased CYP46A1 expres-
sion are in line with the enhancement in cognitive function observed in vivo in CYP46A1 transgenic mice13 and 
with the cognitive deficit observed in Cyp46a1−/− mice12. Strikingly, all changes in neuronal morphology and 
synaptic proteins induced by CYP46A1, are impaired by the pharmacological inhibition of GGTase-I activity. 
This is coherent with the fact that CYP46A1 increases geranylgeranylation of sGTPases by activating the meva-
lonate pathway, as previously described by our group15. Moreover, a recent report shows that administration of 
GGTi-2147, a GGTase-I inhibitor, inhibits basal- and activity-dependent dendritic spine formation in vivo and, 
to the respective area. Scale bar: 20 μm. Data represents mean values ± SEM from at least three independent 
experiments and is expressed as fold change over control. (B) Quantitation of dendritic protrusion density. 
Dendritic protrusions of 21 DIV neurons exhibiting GFP and immunostained for p-Trk were quantified and 
the percentage of co-localization with p-Trk immunostaining was determined. Images are representative 
of GFP and p-Trk immunostaining in AdControl and AdCYP-transduced neurons treated with vehicle or 
cholesterol. Scale bar: 5 μm. Data represents mean values ± SEM from at least three independent experiments 
and is expressed as number of protrusions per μm of the respective dendrite. (C) Cholesterol content in crude 
synaptosomal (P2) fraction of WT and C46-HA mouse brain. Total cholesterol levels were determined with 
the Amplex®Red cholesterol determination kit in P2 fractions obtained from brain cortex of WT and C46-HA 
mice. Data represents mean values ± SEM and is expressed as μg of cholesterol per mg of protein. Statistical 
analysis was performed by Student’s t-test (**p < 0.01). (D,E) Crude synaptosomal (P2) fractions of WT and 
C46-HA mouse brain were subjected to Western Blot analysis for p-Trk and TrkB (D) and Rac1 (E). Data 
represents mean values ± SEM and is expressed as p-Trk/TrkB ratio or Rac1 levels in arbitrary units. β-actin was 
used as loading control. Statistical analysis was performed by Student’s t-test (*p < 0.05 **p < 0.01).
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more importantly, decreases learning and memory25, highlighting an important role of this prenyltransferase in 
the CNS.
Analysis of brain cortex tissue from C46-HA mice, and primary cultures of rat cortical neurons transfected 
or transduced with vectors encoding CYP46A1, led us to the conclusion that CYP46A1 induces Trk phospho-
rylation. It is conceivable that the mild decrease in membrane cholesterol content induced by CYP46A1 affects 
membrane lipid composition. In turn, this might promote higher chances of Trk clustering and therefore favor 
dimerization, facilitating its auto-phosphorylation. It has been suggested that the increase in membrane sphyn-
gomyelin:cholesterol ratio induces TrkB activation in neurons26. The authors propose that, since sphyngomyelin 
can facilitate lipid packaging, it might favour TrkB activation, and demonstrated that increased levels of sphyngo-
myelin is an important mechanism for sustaining TrkB activity, in addition to BDNF activation. In line with this 
idea, CYP46A1-induced reduction of membrane cholesterol might increase the ratio sphingomylein:cholesterol 
ratio and lead to a ligand-free Trk activation. These receptors regulate several features in the CNS, such as syn-
aptic strength and plasticity or neuronal survival and differentiation27,28. Furthermore, it has been reported that 
BDNF-dependent TrkB activation leads to an interaction with GGTase-I, increasing its prenylation activity, which 
was shown to be essential for dendritic outgrowth16. These reports prompted us to determine if Trk phosphoryl-
ation induced by CYP46A1 was also translated into higher interaction with GGTase-I, and to increased gera-
nylgeranylation activity. Indeed, Co-IP experiments using extracts from the brain cortex of C46-HA mice show 
that there is an increased protein association between p-Trk and GGTase-I, probably due to the overall increase 
in p-Trk levels in the brains of C46-HA mice. Accordingly, ectopic expression of CYP46A1 in vitro increases 
GGTase-I activity, and this effect is abolished by the pharmacological inhibition of Trk receptor. Importantly, the 
phosphorylation of Trk mediated by CYP46A1 is not affected by GGTase-I inhibition, which confirms a causal 
relationship. Therefore, activation of the p-Trk-GGTase-I axis by CYP46A1, implies firstly the phosphorylation 
of Trk, which consequently leads to increased GGTase-I activity. One of the aims of this work was to evaluate 
the changes in dendritic outgrowth in response to an acute increase of CYP46A1 expression, however, it would 
Figure 7. CYP46A1 increases synaptic genes mRNA levels. Real-time PCR (qPCR) analysis was performed 
in primary cultures of rat cortical neurons 19 DIV transduced with AdControl or AdCYP adenovirus 
and maintained for 48 hours. (A) qPCR analysis of human CYP46A1 mRNA levels. Data represents mean 
values ± SEM from at least three independent experiments and is expressed as 2−ΔCt. (B) qPCR analysis of Bdnf, 
Arc, Gria2, Grin1, Grin2a, Grin2b and C-fos mRNA levels. Values were normalized to the internal standard 
GAPDH Data represents mean values ± SEM from at least three independent experiments and is expressed 
as fold to the AdControl. Statistical analysis was performed by Student’s t-test (*p < 0.05). (C) qPCR analysis 
of  Arc, Gria2 and Grin2ba mRNA levels. 24 hours after transduction cells were incubated with 100 nM GGTI-
2133, 100 nM K252a or 10 μM Chol:MBCD. Values were normalized to the internal standard GAPDH. Data 
represents mean values ± SEM from at least three independent experiments and is expressed as fold to the 
AdControl. Statistical analysis was performed by Student’s t-test (*p < 0.05).
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also be interesting, in the future, to characterize the dendritic arbor throughout neuronal maturation, in neurons 
subjected to a sustained increase of CYP46A1 levels.
Although the p-Trk-GGTase-I axis is shown to be crucial for increased dendritic outgrowth mediated by 
CYP46A1, the increase in dendritic protrusion density elicited by CYP46A1 is not dependent on Trk phospho-
rylation. On the other hand, inhibition of GGTase-I abolishes the increased protrusion density mediated by 
CYP46A1, but maintains the increase in the percentage of p-Trk that co-localizes with dendritic protrusions. 
Morphogenesis and maintenance of these dynamic structures is intimately linked to the degree of actin polym-
erization, which in turn is tightly regulated by sGTPases of the Rho-family21,29. Therefore, it is plausible that the 
activation of the mevalonate pathway and subsequent activation of sGTPases induced by CYP46A115 is suffi-
cient for the specific morphological effect of increasing the number of protrusions, in a Trk-independent man-
ner. Accordingly, we found a significant increase in Rac1 levels in crude synaptosomal fractions prepared from 
C46-HA mouse cortex.
Furthermore, consistent with the increase in synaptic proteins and dendritic protrusions we also observed 
that CYP46A1 increases the mRNA levels of the synaptic genes Arc, Gria2 and Grin2b, which is depedent on the 
reduction of cholesterol levels.
Indeed, cholesterol supplementation abolishes the increased mRNA levels of synaptic genes, Trk phosphoryla-
tion levels, the increase of dendritic outgrowth elicited by the p-Trk-GGTase-I axis and the induction of dendritic 
protrusion density mediated by GGTase-I. Moreover, we found a striking increase of p-Trk in the crude synapto-
somal fraction prepared from brain cortex obtained from C46-HA mice. Although total cholesterol levels in the 
brains of C46-HA mice do not change13, cholesterol content in the synaptosomal P2 fraction is lower when com-
pared to wild-type animals. These results, suggest that although CYP46A1 activity does not affect total cholesterol 
levels in the brain, it might be inducing permanent changes at particular cells and/or sub-cellular compartments.
Furthermore, since it has been shown that 24OHC has several effects on neuronal cells15,30–33, one could con-
sider that CYP46A1-mediated effects might be underlined by an increased production of this oxysterol. However, 
we have found that 24OHC has the opposite effect of CYP46A1 regarding dendritic outgrowth in vitro, which fur-
ther corroborates the idea that cholesterol loss per se is the trigger for the observed effects induced by CYP46A1.
It is widely known that cholesterol is essential for proper neuronal function. In fact, several postsynaptic 
processes important for synaptic function and morphology depend on cholesterol-rich lipid rafts34. Cholesterol 
reduction using 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitors–statins-has led to conflicting 
data. Atorvastatin was reported to cause neurite loss35, and to induce neurite outgrowth in rat cortical neurons36 
through different mechanisms. It was also reported that cholesterol depletion by MBCD increases neurite out-
growth in hippocampal neurons, while both cholesterol loading and depletion inhibits neurite outgrowth in 
cortical neurons37. Importantly, the statins/MBCD approach induces an artificial, abrupt and drastic cholesterol 
depletion that is not accompanied by a feedback activation of the mevalonate pathway as it happens by acti-
vating the endogenous pathway of brain cholesterol metabolism through increased CYP46A1 expression13,15,38. 
Regarding synaptic function, cholesterol reduction mediated by statins or acute extraction by MBCD causes an 
immediate collapse of spines39. However, it has been recently shown that the induction of LTP, mediated by the 
glutamate receptor N-methyl-D-aspartate receptor (NMDAR), leads to a 40–50% reduction in neuronal cho-
lesterol which, in turn, leads to further synaptic potentiation. On the other hand, cholesterol supplementation 
completely abolishes glutamate-induced LTP40. Furthermore, a 20–30% reduction in cholesterol content through 
pharmacological manipulation, has been shown not to have any toxic effect on hippocampal neurons, in fact, 
it actually enhances excitatory synaptic transmission and facilitates LTP40. Interestingly, it has been established 
that cholesterol loss arising from glutamatergic synaptic input, is due to an increase in CYP46A1 activity41. These 
results are in line with our observations indicating that CYP46A1-mediated cholesterol loss increases the levels 
of synaptic proteins and genes, accompanied by an increment in dendritic protrusion density. Actually, choles-
terol accumulation is deleterious to neurons. Increased membrane cholesterol of cultured neurons recapitulates 
Alzheimer’s early phenotype18 and increases neuronal susceptibility to beta-amyloid peptide-induced toxicity19. 
Furthermore, in vivo accumulation of cholesterol due to silencing of CYP46A1, leads to amyloidogenesis, neu-
ronal death and cognitive impairment11. According to our results, CYP46A1-mediated cholesterol metabolism is 
beneficial for neuronal development and activity, which is in line with other in vivo studies13,14.
In conclusion, this study shows that brain cholesterol metabolism, orchestrated by CYP46A1, triggers an 
increase in neuronal dendritic outgrowth and synaptic markers, in a GGTase-I- and Trk-dependent fashion. 
Furthermore, we conclude that the overall effect of CYP46A1 in neurons arises from GGTase-I and Trk acting 
in both a concerted and independent fashion. These molecular events might underline major outcomes in vivo, 
such as changes in high-order brain functions. In fact, as also described in a previous report17, we have detected 
an increase in endogenous CYP46A1 expression during neuronal maturation in vitro which might underline, to 
some extent, morphological and functional changes that occur during this process in vivo, by activating sGTPases 
and Trk pathways. The understanding of how cholesterol homeostasis affects brain function is extremely relevant, 
particularly since many neurodegenerative and neurological disorders have brain cholesterol homeostasis 
dysregulation as a common feature.
Materials and Methods
Reagents and antibodies. The following primary antibodies were used: anti-FLAG®M2 (clone M2, 
F1804; Sigma-Aldrich Inc., St Louis, MO, USA), anti-microtubule-associated protein 2 (MAP2) (AB5622, Merck 
Millipore Corporation., Darmstadt, Germany), anti-postsynaptic density protein 95 (PSD95) (MAB1598, Merck 
Millipore), anti-SH3 and multiple ankyrin repeat domains 3 (Shank3) (sc-30193, Santa Cruz Biotechnology Inc., 
Santa Cruz, CA, USA), anti-Synaptotagmin (ab77314, Abcam, Cambridge, UK) anti-Synaptophysin (MAB5258, 
Merck Millipore), anti p-Trk (sc-8058; Santa Cruz), anti-GGTase-Iβ (sc-1899, Santa Cruz), anti-TrkB (sc-12, 
Santa Cruz) and anti-β-actin (A5541, Sigma). Geranylgeranyl pyrophosphate (GGPP) ammonium salt, Triton™ 
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X-100, Tween® 20, IGEPAL®, dimethyl sulfoxide (DMSO), filipin III, 24S-hydroxycholesterol and the chem-
ical inhibitors GGTi-2133 and K252a were all purchased from Sigma. The phosphatase inhibitor cocktail 
(04906837001) and the protease inhibitor cocktails 1 and 2 (11697498001 and 11836170001, respectively) were 
purchased from Roche Diagnostics (GmbH, Penzberg, Germany). The fluorogenic substrate used for GGTase-I 
activity assay was dansyl-GCVLL (Biosynthesis, Lewisville, TX, USA). Phalloidin was obtained from Molecular 
Probes®, Thermo Fisher Scientific Inc. (Waltham, MA, USA).
Cholesterol:Methyl-β-Cyclodextrin complexes. Cholesterol:methyl-β-cyclodextrin complexes 
(Chol:MBCD) were produced as previously described42. Briefly, 1 g methyl-β-cyclodextrin was dissolved in 
phosphate-buffered saline (PBS) and heated to 80 °C in water bath with continuous stirring. In parallel, 30 mg of 
cholesterol were dissolved in 400 μl isopropanol/chloroform (2:1). The cholesterol solution was added in aliquots 
of 50 μl to the MBCD solution, stirring until it solubilized completely before additional aliquots were added. After 
cooling, the final solution was stored at room temperature.
Primary cultures of cortical neurons. Primary cultures of rat cortical neurons were prepared from 17- to 
18-day-old Wistar rat fetuses as described previously43 with minor modifications. In short, pregnant rats were 
sacrificed in a CO2 chamber and the fetuses were collected in Hank’s balanced salt solution (HBSS) with Ca2+ and 
Mg2+ (Gibco™, Thermo Fisher) and rapidly decapitated. After removal of meninges and white matter, the brain 
cortex was collected in HBSS without Ca2+ and Mg2+ (HBSS-2). The cortex was then mechanically fragmented, 
transferred into a 0.05% trypsin solution, and incubated for 15 min at 37 °C. Following trypsinization, cells were 
washed twice in HBSS-2 containing 10% fetal bovine serum (FBS) and resuspended in Neurobasal medium, sup-
plemented with 0.5 mM L-glutamine, 25 μM L-glutamic acid, 2% B-27 supplement, and 12 mg/mL gentamicin. 
Isolated neurons were plated with a density around 640/mm2 on culture plates pre-coated with poly-D-lysine, 
and maintained at 37 °C in a humidified atmosphere of 5% CO2. Half of the medium of the neuronal primary 
cultures was changed every 3–4 days. Glutamic acid was only added into the medium when plating the cells. All 
the subsequent media changes and cell treatments were free from glutamic acid. HBSS buffers, Neurobasal, B-27, 
L-glutamine, FBS and gentamicin were all purchased from Gibco™, Thermo Fisher Scientific Inc. (Waltham, MA, 
USA). L-glutamic acid and poly-D-lysine were purchased from Merck Millipore and Sigma, respectively.
Transfection and transduction. Neurons were transfected with a control plasmid harboring a CMV 
promoter (pCMV) or the same plasmid encoding the FLAG-tagged hCYP46A1 (pCMV-FLAG-CYP46A1) 
(described in our previous work15) using Lipofectamine® 2000 (Invitrogen, Thermo Fisher) according to man-
ufacturer’s instructions. Briefly, culture media was changed to fresh neurobasal media with all the supplements 
previously mentioned, except for gentamicin. Subsequently, Opti-MEM® (Gibco™) containing the mixture of 
Lipofectamine® 2000 and DNA (2.5 μl: 1 μg) was added and cells were incubated for 4 hours at 37 °C in a humid-
ified atmosphere of 5% CO2. Afterwards, the transfection media was discarded and regular neuronal media was 
added.
Adenovirus encoding GFP or both GFP and FLAG-tagged CYP46A1 were generated by using the pAdTrack/
pAdEasy system. GFP and FLAG-tagged CYP46A1 are expressed from two independent promoters. Adenovirus 
titration was done by flow cytometry using Guava EasyCyte 5HT® (Merck Millipore)44,45. Neurons were trans-
duced overnight with adenovirus at a titer of 7.5 × 107 green fluorescent units (gfu) per ml of media.
Immunocytochemistry and image analysis. Neurons were fixed with a solution of 4% paraformal-
dehyde in PBS. Subsequently, cells were rinsed with PBS, and permeabilized with a solution of triton X-100 
0.1% in PBS for 20 min. Afterwards, cells were rinsed with PBS once more and blocking solution (FBS 10% and 
Tween® 20 0.05% in PBS) was added for 1 hour at room temperature. After blocking, the cells were incubated 
overnight at 4 °C with the respective primary antibodies diluted in blocking solution. Unbound primary anti-
bodies were washed with PBS, and neurons were incubated with the respective secondary antibodies and dyes 
(DAPI for nuclear staining, filipin III for free cholesterol staining, or phalloidin for F-actin staining) diluted in 
blocking solution for 1 hour at room temperature. Fluorescence visualization was performed in an AxioScope.A1 
microscope (Zeiss, Germany) with an AxioCam HRm camera (Zeiss). Morphological analysis, fluorescence and 
co-localization quantification were performed using NIH ImageJ 1.46r software. Dendritic protrusions number 
(either mushroom-shape, spines or filopodia) was counted manually using ImageJ in order to determine the pro-
trusion density, corresponding to the number of protrusions per length unit of the respective dendrite.
Sholl analysis was performed using the plug-in “sholl analysis” for ImageJ software. The software determined 
the number of intersections between the dendritic arborization and concentric circles created around the neu-
ronal soma. The increment distance between each circle was set to 1 μm. The values of intersections given by the 
software were plotted against the distance from the soma.
Mouse brain cortical tissue. Brain cortical tissue samples were obtained from female wild-type (WT) and 
homozygous HA-tagged CYP46A1 transgenic (C46-HA) mice, previously described and characterized13. Briefly, 
CYP46A1 heterozygous transgenic mice from the sixth generation were inbred for three additional generations 
in order to obtain the homozygous mice.
Total cell and tissue extracts. Total cell extracts were obtained by harvesting the cells in PBS and resus-
pended in lysis buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% Triton-X 100) supplemented with 1 mM dith-
iothreitol (DTT), 1 mM sodium orthovanadate, 10 mM sodium fluoride and protease inhibitors cocktail 1. Tissue 
from mouse brain was also homogenized in lysis buffer with a motor-driven Bio-vortexer (NO1083; Biospec 
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Products, Bartlesville, OK, USA). Both cell and tissue samples were incubated at 4 °C, for 30 min. Afterwards, the 
samples were sonicated four times for 4 seconds each, on ice, followed by centrifugation at 12,000 × g for 15 min 
at 4 °C. The supernatant was recovered and protein concentration was determined by the Bradford method and 
the extracts were stored at −80 °C until further use.
Crude synaptosomal fractions. Crude synaptosomal (P2) fractions were obtained from neurons and 
mouse brain cortex tissue as previously described46 with minor modifications. The cell pellet or tissue slices 
were homogenized in homogenization buffer (4 mM HEPES-NaOH pH 7.3, 0.32 M sucrose) supplemented with 
1 mM DTT, 1 mM sodium orthovanadate, 10 mM sodium fluoride and protease inhibitors cocktail 1. Cells were 
homogenized by 20 passages through a 23 gauge needle attached to a 1-mL syringe and tissue was homogenized 
with a motor-driven Bio-vortexer (Biospec Products). Samples were centrifuged at 800 × g for 10 minutes at 4 °C. 
The pellet was discarded and supernatant was recovered and subjected to another centrifugation at 9.200 × g for 
15 minutes at 4 °C. The resulting pellet was resuspended in 100 μl of homogenization buffer and the samples were, 
once more, centrifuged at 10.200 × g at 4 °C. The supernatant was discarded and the pellet resuspended in 100 μl 
of homogenization buffer. Protein concentration was determined by Bradford method and the extracts were 
stored at −80 °C until further use.
Co-immunoprecipitation (Co-IP). Cortex tissue slices from mouse brain were lysed and homogenized 
in Co-IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl 1 mM ethylenediaminetetraacetic acid [EDTA], 1% 
IGEPAL® and 10% glycerol) supplemented with 1 mM sodium orthovanadate, 10 mM sodium fluoride and pro-
tease inhibitors cocktail 1. After incubation at 4 °C, for 30 min, samples were centrifuged at 12.000 × g for 15 min 
at 4 °C. The supernatant was recovered and protein concentration was determined by the Bradford method. 
Samples concentration were adjusted to 2 mg/ml in 500 μl, and pre-cleared with A/G agarose beads saturated 
with salmon sperm DNA and bovine serum albumin (Upstate, Billerica, MA) for 1 hour at 4 °C. Subsequently, 
the samples were centrifuged at 2.000 × g for 2 min at 4 °C to pellet the beads and recover the cleared supernatant, 
which was incubated overnight in a rotator at 4 °C with 3 μg of the anti-p-Trk or anti-GGTase-Iβ antibodies. 
Afterwards, the samples were incubated with A/G agarose beads for 2 hours at 4 °C in a rotator for the binding of 
the beads to the immunocomplexes. These bead-complexes were pulled-down, washed in Co-IP buffer 3 times, 
resuspended in Laemmli buffer and heated at 95 °C for 5 min to elute the proteins. Beads were pulled-down and 
the samples were subsequently subjected to Western blot analysis. In parallel, 50 μg of pre-cleared extract of each 
tissue sample were used as input. Non-specific IgGs were used as negative controls.
Western blot. Proteins were subject to SDS-PAGE gels, electroblotted onto Immobilon P membrane 
(IPVH00010, Merck Millipore) and incubated with specific antibodies. Results were quantified using the Quantity 
One version densitometry analysis software (Bio-Rad Laboratories Inc., Hercules, CA, USA).
GGTase-I activity. GGTase-I activity was measured in 96-well plates as previously described16,47 with 
minor modifications. Briefly, cells were lysed with lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM MgCl2, 50 μM 
ZnCl2, 150 mM KCl, 0.2% octyl-β-D-glucopyranoside and 1% Triton-X 100) supplemented with 1 mM DTT, 
phosphatase and protease inhibitor cocktail 2. 40 μg of total cell extract were mixed with the reaction buffer 
Gene Sequence (5′–3′)
Bdnf
5′ AGCTGAGCCGTGTGTGACAGT 3′ (fwd)
5′ ACCCATGGGATTACACTTGG 3′ (rev)
Arc
5′ CCCTGCAGCCCAAGTTCAAG 3′ (fwd)
5′ GAAGGCTCAGCTGCCTGCTC 3′ (rev)
Gria2
5′ GACTCTGGCTCCACTAAAGA 3′ (fwd)
5′ AGTCCTCACAAACACAGAGG 3′ (rev)
Grin1
5′ AAGTTCACCTATGACCTTTACC 3′ (fwd)
5′ CATGACCACCTCACCGAT 3′ (rev)
Grin2a
5′ GACAGCAAGAGGAGCAAGTCTC 3′ (fwd)
5′ CTCAAGGATGACCGAAGATAGC 3′ (rev)
Grin2b
5′ GAGTCTGGCTCCACTAAAGA 3′ (fwd)
5′ AGTCCTCACAAACACAGAGG 3′ (rev)
c-fos
5′ AGCATGGGCTCCCCTGTCA 3′ (fwd)
5′ GAGACCAGAGTGGGCTGCA 3′ (rev)
Cyp46a1
5′ GAAGGTCATGCTGGAGGGTATC3′ (fwd)
5′ CGTAACAGGCGGATGCTCTC 3′ (rev)
CYP46A1
5′ TGCGGTCAACGTCTTCCACAA 3′ (fwd)
5′ CTTGGCCGAAGAGTCTCTCACCA3′ (rev)
Gapdh
5′ GGGTGTGAACCACGAGAAAT 3′ (fwd)
5′ ACTGTGGTCATGAGCCCTTC 3′ (rev)
Table 1.  List of primers used for qPCR.
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(50 mM Tris-HCl pH 7.5, 50 mM MgCl2, 50 μM ZnCl2, 20 mM KCl, 0.2% octyl-β-D-glucopyranoside) supple-
mented with 10 μM dansyl-GCVLL, 10 μM GGPP, 1 mM DTT, and phosphatase and protease inhibitor cocktails. 
Geranylgeranylation of dansyl-GCVLL results in a significant enhancement in fluorescence intensity. The reac-
tion was followed by recording the fluorescence intensity (excitation: 360 ± 40 nM and emission: 528 ± 20 nm) for 
10 min using a Synergy 2 Multi-Mode Reader (BioTek Instruments, Inc., Winooski, VT, USA). The initial velocity 
of the reaction was determined from the slope of the linear stage.
Total and free cholesterol levels. Total cholesterol was quantified using the Amplex® Red cholesterol 
assay kit (Invitrogen, Thermo Fischer) according to the manufacturer’s instructions. P2 fraction extracts of 
mouse brain tissue were placed in a 96-well plate, and the reaction was initiated by adding the Amplex® Red 
reagent/HRP/cholesterol oxidase/cholesterol esterase working solution to each well. The plate was incubated for 
30 min at 37 °C. Fluorescence measurements were performed in a GloMax®-Multi Detection System (Promega 
Corporation, Madison, USA). The protocol to determine free cholesterol in total cell extracts was similar to the 
one described above, although the working solution did not contain cholesterol esterase. Cholesterol levels were 
normalized with total protein levels and expressed as μg of cholesterol per mg of protein.
Expression analysis. Total cell RNA was extracted using Isol-RNA Reagent (5 prime) following manufac-
turer’s instructions. The RNA was incubated with a recombinant DNase (04716728001, Roche) according to the 
manufacurer’s instructions to ensure there was no DNA contamination in the RNA samples. Subsequently, cDNA 
synthesis was performed using the NZY First-Strand cDNA Synthesis Kit (NZYTech, Lda., Lisbon, Portugal) 
according to manufacturer’s instructions. Real-Time PCR (qPCR) analysis for the rat brain-derived neurotrophic 
factor (Bdnf); activity-regulated cytoskeleton-associated protein (Arc); glutamate receptor, ionotropic, AMPA 
2 (Gria2); glutamate receptor, ionotropic, N-methyl D-aspartate 1 (Grin1); glutamate receptor, ionotropic, 
N-methyl D-aspartate 2A (Grin2a), glutamate receptor, ionotropic, N-methyl D-aspartate 2B (Grin2b); FBJ 
murine osteosarcoma viral oncogene homolog (c-fos); glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and 
the human and rat cholesterol 24-hydroxylase (CYP46A1) was performed using SensiFAST™ SYBR® Hi-ROX 
Kit (Bioline USA Inc, Taunton, MA, USA) in an ABI 7300 sequence detection system (Applied Biosystems, Foster 
City, CA, USA) and specific primers (Table 1). The mRNA levels of the genes of interest were normalized to the 
mRNA levels of Gapdh and expressed as fold changes relative to controls, using the ΔΔCt method.
24S-hydroxycholesterol levels. A colorimetric, competitive ELISA kit (ADI-900-210-0001; Enzo 
Biochem, Inc., Farmingdale, New York) was used for the quantitative determination of 24S-hydroxycholesterol 
(24OHC) levels in culture media, following the manufacturer’s protocol. Absorbance was measured in the 
GloMax®-Multi Detection System.
Adenylate kinase cytotoxicity assay. The ToxiLight™ BioAssay Kit (Lonza, Basel, Switzerland) is based 
on a bioluminescent assay designed to measure the release of the enzyme, adenylate kinase (AK), from damaged 
cells. Brifely, cell culture supernatants were mixed with AK detection reagent, incubated 5 minutes at room tem-
perature and luminescence was measured using GloMax®-Multi Detection System, according to manufacturer’s 
protocol.
Lactate dehydrogenase cytotoxicity assay. General cell death was assessed by measuring lactate dehy-
drogenase (LDH) activity in culture media supernatants, mixed with a solution of lactate (substrate), tetrazolium 
salt (coloring solution), and NAD (cofactor), according to the manufacturer’s protocol (Roche Applied Science, 
Indianapolis, IN, USA). Plates were protected from light and incubated for 15  minutes at room temperature. 
Finally, absorbance was measured at 490 nm, with 620 nm as reference, using a Bio-Rad model 680 microplate 
reader (Bio-Rad Laboratories, Hercules, CA, USA).
Statistical analysis. Statistical analysis was performed using the Student’s t-test, one-way or the two-way 
ANOVA tests followed by Tukey multiple comparisons test. All analysis were performed using the GraphPad 
Prism version 5.01 for Windows, GraphPad Software (La Jolla California USA, www.graphpad.com).
Ethics statement. Wistar rats were maintained in an animal facility at Instituto de Higiene e Medicina Tropical 
(IHMT), licensed by the Portuguese Food and Veterinary Directorate General (DGAV). The isolation of cortical 
neurons was performed by an investigator accredited with FELASA level C. All procedures were performed in 
accordance with the Portuguese national laws and European guidelines concerning laboratory animals welfare. 
Regarding WT and C46-HA mice, all procedures were approved by the local ethical committee of Karolinska 
Institutet, Stockholm (permit numbers: S135-12, S105-11 and S139-10), and performed in accordance with Swedish 
national and local animal care and use guidelines. All the efforts were made to minimize the suffering of the animals.
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